Ozempic & Wegovy in Europe: What to Know in 2026
7 min read · Updated September 2026
Ozempic and Wegovy are among the most searched names in European health, yet many people do not realise they are the same active compound. This guide explains what they are, how they relate to semaglutide, how European regulation treats them, and why a specialist-led approach is the appropriate route.
Ozempic and Wegovy are both semaglutide
Ozempic and Wegovy are brand names for the same active peptide, semaglutide, a GLP-1 receptor agonist. They differ mainly in approved use and dosing: Ozempic is associated with blood-sugar management in type 2 diabetes, and Wegovy with weight management. Recognising that they share one active compound makes the whole topic far easier to understand.
How they are regulated in Europe
Across the European Union, semaglutide under any brand is a prescription-only medicine. It cannot be advertised directly to the public, and it is meant to be prescribed and monitored by a licensed clinician. European supply has also been affected at times by global demand outpacing availability. For all these reasons the appropriate route is a consultation first, not a blind purchase.
The wider semaglutide picture
Semaglutide sits in a class alongside tirzepatide (a dual GIP and GLP-1 agonist) and retatrutide (a triple agonist adding glucagon). For anyone exploring options, the useful question is not which brand but which compound and protocol suits their profile, which is a matter for a licensed clinician rather than a headline.
How SupplifyMe approaches it
SupplifyMe is consultation-led and educational: you take a short assessment, get matched, and confirm suitability and a protocol with a specialist before anything is arranged. Where a semaglutide protocol is appropriate, pens are lab-tested, pre-mixed and pre-dosed, and couriered cold-chain in insulated packaging across Europe, then refrigerated at 2 to 8C for storage.
Related peptides
Frequently asked
What is the difference between Ozempic and Wegovy?
Both are brand names for the same active peptide, semaglutide. They differ mainly in approved use and dosing: Ozempic is associated with blood-sugar management in type 2 diabetes and Wegovy with weight management.
Are Ozempic and Wegovy legal in Europe?
Semaglutide under any brand is a prescription-only medicine across the European Union, prescribed and supervised by a licensed clinician, and it cannot be advertised directly to the public. The appropriate route is a consultation rather than a blind purchase.
Do I need a prescription in the EU?
Yes. Semaglutide is prescription-only across Europe, so your suitability, dose and cycle are confirmed with a licensed clinician rather than self-prescribed.
Is there an alternative to Ozempic and Wegovy?
Semaglutide sits in a class alongside tirzepatide and retatrutide, which differ in mechanism and dosing. The right option is matched to your profile on a consultation rather than chosen by brand name.
For educational purposes only and not intended to diagnose, treat, cure or prevent any disease. Not a substitute for professional medical advice. Products are intended for adults 21+.